| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACRBP
|
acrosin binding protein
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ATG16L2
|
autophagy related 16-like 2 (S. cerevisiae)
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L12
|
BCL2-like 12 (proline rich)
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BSG
|
basigin (Ok blood group)
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C3
|
complement component 3
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
|
CAD
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP8AP2
|
caspase 8 associated protein 2
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CD19
|
CD19 molecule
|
|
CD247
|
CD247 molecule
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD8A
|
CD8a molecule
|
|
CD96
|
CD96 molecule
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX1
|
caudal type homeobox 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CDX4
|
caudal type homeobox 4
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CENPA
|
centromere protein A
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CLU
|
clusterin
|
|
COMT
|
catechol-O-methyltransferase
|
|
CREBBP
|
CREB binding protein
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSMD1
|
CUB and Sushi multiple domains 1
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSD
|
cathepsin D
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DRD2
|
dopamine receptor D2
|
|
EFNA1
|
ephrin-A1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EMP3
|
epithelial membrane protein 3
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETV6
|
ets variant 6
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FAT1
|
FAT atypical cadherin 1
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FHIT
|
fragile histidine triad
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOXM1
|
forkhead box M1
|
|
FOXP3
|
forkhead box P3
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GDF15
|
growth differentiation factor 15
|
|
GGH
|
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
|
|
GLI1
|
GLI family zinc finger 1
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRM2
|
glutamate receptor, metabotropic 2
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HPX
|
hemopexin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IRF4
|
interferon regulatory factor 4
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
JAK2
|
Janus kinase 2
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLK14
|
kallikrein-related peptidase 14
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LDHA
|
lactate dehydrogenase A
|
|
LEP
|
leptin
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAP1LC3A
|
microtubule-associated protein 1 light chain 3 alpha
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR10A
|
microRNA 10a
|
|
MIR10B
|
microRNA 10b
|
|
MIR126
|
microRNA 126
|
|
MIR145
|
microRNA 145
|
|
MIR185
|
microRNA 185
|
|
MIR215
|
microRNA 215
|
|
MIR296
|
microRNA 296
|
|
MIR29C
|
microRNA 29c
|
|
MIR30A
|
microRNA 30a
|
|
MIR367
|
microRNA 367
|
|
MIR410
|
microRNA 410
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NEU3
|
sialidase 3 (membrane sialidase)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFRKB
|
nuclear factor related to kappaB binding protein
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOVA1
|
neuro-oncological ventral antigen 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NT5C2
|
5'-nucleotidase, cytosolic II
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
NUP214
|
nucleoporin 214kDa
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
P2RY8
|
purinergic receptor P2Y, G-protein coupled, 8
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDCD2
|
programmed cell death 2
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PGR
|
progesterone receptor
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PICK1
|
protein interacting with PRKCA 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PML
|
promyelocytic leukemia
|
|
PON1
|
paraoxonase 1
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PROM1
|
prominin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RANBP2
|
RAN binding protein 2
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
RUNX1
|
runt-related transcription factor 1
|
|
S100A1
|
S100 calcium binding protein A1
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
SDC1
|
syndecan 1
|
|
SELE
|
selectin E
|
|
SELL
|
selectin L
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SIGLEC7
|
sialic acid binding Ig-like lectin 7
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SRRT
|
serrate, RNA effector molecule
|
|
ST2
|
suppression of tumorigenicity 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STC1
|
stanniocalcin 1
|
|
STK11
|
serine/threonine kinase 11
|
|
SWAP70
|
SWAP switching B-cell complex 70kDa subunit
|
|
SYK
|
spleen tyrosine kinase
|
|
SYNM
|
synemin, intermediate filament protein
|
|
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFF1
|
trefoil factor 1
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
TLR4
|
toll-like receptor 4
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TYMS
|
thymidylate synthetase
|
|
VCAN
|
versican
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WT1
|
Wilms tumor 1
|
|
WWC1
|
WW and C2 domain containing 1
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
YBX1
|
Y box binding protein 1
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZNF652
|
zinc finger protein 652
|
